Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8271)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 18, 2021 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Transplantation
ISSN
2220-3230
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Boonpheng B, Hansrivijit P, Thongprayoon C, Mao SA, Vaitla PK, Bathini T, Choudhury A, Kaewput W, Mao MA, Cheungpasitporn W. Rituximab or plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis after kidney transplantation: A systematic review and meta-analysis. World J Transplant 2021; 11(7): 303-319 [PMID: 34316454 DOI: 10.5500/wjt.v11.i7.303] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3230/full/v11/i7/303.htm |
| Number | Citing Articles |
| 1 |
Michelle N. Rheault, Sandra Amaral, Margret Bock, Eileen Tsai Chambers, Blanche Chavers, Mireile El Ters, Rouba Garro, Rasheed Gbadegesin, Amit Govil, Lyndsay Harshman, Hatem Amer, David K. Hooper, Ajay K. Israni, Samy Riad, Junichiro Sageshima, Ron Shapiro, Michael Seifert, Jodi Smith, Randall Sung, Christie P. Thomas, Qi Wang, Priya S. Verghese. A randomized controlled trial of preemptive rituximab to prevent recurrent focal segmental glomerulosclerosis post-kidney transplant (PRI-VENT FSGS): protocol and study design. Frontiers in Nephrology 2023; 3 doi: 10.3389/fneph.2023.1181076
|
| 2 |
Simon R. Knight. Transplant Trial Watch. Transplant International 2023; 36 doi: 10.3389/ti.2023.11816
|
| 3 |
Andrea Angeletti, Maurizio Bruschi, Xhuliana Kajana, Edoardo La Porta, Sonia Spinelli, Gianluca Caridi, Francesca Lugani, Enrico Eugenio Verrina, Gian Marco Ghiggeri. Biologics in steroid resistant nephrotic syndrome in childhood: review and new hypothesis-driven treatment. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1213203
|
| 4 |
Syeda Behjat Ahmad, Yonatan Peleg, Wooin Ahn. Current approaches to overcome recurrent focal segmental glomerulosclerosis after kidney transplantation. Current Opinion in Nephrology & Hypertension 2024; 33(1): 61 doi: 10.1097/MNH.0000000000000946
|
| 5 |
Charlotte Uro-Coste, Céline Lambert, Vincent Audard, Lionel Couzi, Sophie Caillard, Matthias Büchler, Arnaud Del Bello, Paolo Malvezzi, Vincent Pernin, Charlotte Colosio, Laurent Mesnard, Dominique Bertrand, Frank Martinez, Didier Ducloux, Coralie Poulain, Antoine Thierry, Clément Danthu, Clarisse Greze, Camille Lanaret, Valérie Moal, Alexandre Hertig, Jacques Dantal, Christophe Legendre, Valérie Chatelet, Antoine Sicard, Clément Gosset, Nicolas Maillard, Agnès Duveau, Clémence Petit, Nassim Kamar, Anne-Elisabeth Heng, Dany Anglicheau, Cyril Garrouste. Prophylactic treatment of FSGS recurrence in patients who relapsed on a previous kidney graft. Nephrology Dialysis Transplantation 2024; doi: 10.1093/ndt/gfae108
|
| 6 |
Byung Hwa Park, Ye Na Kim, Ho Sik Shin. New treatment for antibody-mediated rejection: interleukin-6 inhibitors. Clinical Transplantation and Research 2024; 38(1): 1 doi: 10.4285/ctr.23.0069
|
| 7 |
Sophie Gharaei, Hashim Abbas, Durga Anil Kanigicherla. Review of plasma exchange and rituximab for prevention of recurrent focal segmental glomerulosclerosis after a prior graft loss. World Journal of Transplantation 2024; 14(4): 98155 doi: 10.5500/wjt.v14.i4.98155
|
| 8 |
Kamila Szumilas, Aleksandra Wilk, Piotr Wiśniewski, Anna Gimpel, Violetta Dziedziejko, Markus Kipp, Andrzej Pawlik. Current Status Regarding Immunosuppressive Treatment in Patients after Renal Transplantation. International Journal of Molecular Sciences 2023; 24(12): 10301 doi: 10.3390/ijms241210301
|
| 9 |
Liuwei Wang, Lu Yu, Yulin Wang, Yanhong Guo, Zihan Zhai, Lin Tang. Rituximab treatment of adults with primary focal segmental glomerulosclerosis. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-33678-y
|
| 10 |
Rupesh Raina, Swathi Jothi, Dieter Haffner, Michael Somers, Guido Filler, Prabhav Vasistha, Ronith Chakraborty, Ron Shapiro, Parmjeet S. Randhawa, Rulan Parekh, Christopher Licht, Timothy Bunchman, Sidharth Sethi, Guneive Mangat, Joshua Zaritsky, Franz Schaefer, Bradley Warady, Sharon Bartosh, Mignon McCulloch, Khalid Alhasan, Agnieszka Swiatecka-Urban, William E. Smoyer, Anil Chandraker, Hui Kim Yap, Vivekanand Jha, Arvind Bagga, Jai Radhakrishnan. Post-transplant recurrence of focal segmental glomerular sclerosis: consensus statements. Kidney International 2024; 105(3): 450 doi: 10.1016/j.kint.2023.10.017
|
| 11 |
Hye Eun Kwon, Young Hoon Kim, Sang Ah Lee, Jae Jun Lee, Youngmin Ko, Sung Shin, Joo Hee Jung, Frances S. Sung, Chung Hee Baek, Hyosang Kim, Su-Kil Park, Hyunwook Kwon. Post-operative recurrence of focal segmental glomerulosclerosis according to pre-transplant treatment after kidney transplantation. BMC Nephrology 2023; 24(1) doi: 10.1186/s12882-023-03098-1
|
| 12 |
Laura Connelly‐Smith, Caroline R. Alquist, Nicole A. Aqui, Jan C. Hofmann, Reinhard Klingel, Oluwatoyosi A. Onwuemene, Christopher J. Patriquin, Huy P. Pham, Amber P. Sanchez, Jennifer Schneiderman, Volker Witt, Nicole D. Zantek, Nancy M. Dunbar. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue. Journal of Clinical Apheresis 2023; 38(2): 77 doi: 10.1002/jca.22043
|